Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 25, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Oct. 25, 2024 -- Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue, according to a study published in the November issue of The Lancet Neurology.

Tiffany J. Braley, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a randomized, comparative effectiveness trial at two universities in the United States to compare CBT, modafinil, and their combination for the treatment of multiple sclerosis fatigue. A total of 336 adults with multiple sclerosis and problematic fatigue were randomly assigned to receive CBT, modafinil, or both for 12 weeks (114, 114, and 108 individuals, respectively).

The researchers found that CBT, modafinil, and combination therapy were associated with clinically meaningful within-group reductions in the Modified Fatigue Impact Scale (MFIS) of 15.20, 16.90, and 17.30 points, respectively, at 12 weeks. From baseline to 12 weeks, the change in MFIS scores did not differ between the groups; the adjusted total mean difference in MFIS change was 1.88 and 1.20 for CBT and modafinil, respectively, relative to the combination group. For modafinil-containing groups, the most common adverse events included insomnia and anxiety.

"Results of this randomized comparative effectiveness research trial of telephone-based CBT, modafinil, and combination therapy suggest that each treatment offers largely equivalent, clinically meaningful benefits for the effects of multiple sclerosis fatigue in people with multiple sclerosis, with high acceptance, good adherence, and good tolerability," the authors write.

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-26 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords